Atıf İçin Kopyala
Saglam S., Hacisahinogullari H., Ozturk N., Kapran Y., Gulluoglu M., Turkmen C., ...Daha Fazla
Journal of B.U.ON. : official journal of the Balkan Union of Oncology, cilt.20, sa.5, ss.1201-5, 2015 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
20
Sayı:
5
-
Basım Tarihi:
2015
-
Dergi Adı:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.1201-5
-
Anahtar Kelimeler:
gastroentero pancreatic neuroendocrine tumor, LAR, non-functioning tumor, octreotide, survival, SOMATOSTATIN ANALOGS, LANREOTIDE
-
İstanbul Üniversitesi Adresli:
Evet
Özet
Purpose: Benefits of somatostatin analogues have been mostly studied in mixed samples of patients including both functional and non-functional neuroendocrine tumors. This study aimed to examine the response of patients with non-functional metastatic or inoperable gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that received first-line treatment with the somatostatin analogue octreotide LAR.